Clinical Trial: mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM
Study Status: Completed
Recruit Status: RECRUITING
Condition: Gestational Diabetes
Study Type: INTERVENTIONAL
Official Title: Randomized Control Trial to Investigate the Effect of a Smartphone Application for Gestational Diabetes Management on Postpartum Glucose Intolerance
Brief Summary:
Without intervention, approximately 70% of women diagnosed with GDM will develop type 2 diabetes mellitus in their lifetime.Abnormal results of a 2 hour oral glucose tolerance test (OGTT) performed as early as 2 days postpartum are predictive of impaired glucose tolerance 1 year postpartum.The investigators hypothesize that use of the Malama smartphone application to optimize antenatal glycemic control will result in lower incidence of postpartum glucose intolerance, which may decrease long term risk of…
Read more